Bovi-Shield Gold FP5

Infectious Bovine Rhinotracheitis (IBR) virus Bovine Viral Diarrhoea (BVD Type 1 and 2) Parainfluenza 3 (PI3) Bovine Respiratory Syncytial Virus (BRSV) The freeze-dried vaccine is a preparation of modified live virus (MLV) strains of IBR, BVD (types 1 and 2), PI3 and BRSV propagated on an established cell line. An adjuvant sterile diluent is provided to rehydrate the freezedried component. Use only as directed: General Directions: Vaccination of healthy cattle is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 2 ml intramuscularly, in the muscular region of the neck. Foetal protection: Primary Vaccination: Administer a single 2 ml dose to all breeding cows and heifers approximately 1 month prior to breeding. Revaccination: Annual revaccination with a single dose of Bovi-Shield GOLD FP5 is recommended, approximately 1 month prior to breeding. Calves vaccinated before the age of 6 months should be re-vaccinated after 6 months of age to avoid possible maternal interference with immunisation. For safety in pregnant cattle, heifers must receive at least 2 doses of any Bovi-Shield FP vaccine between 6 months of age and breeding, with the second dose administered approximately 1 month prior to breeding. Naive cows also need to receive 2 doses, 3-4 weeks apart, with the second dose administered approximately 1 month prior to breeding. Bovi-Shield® GOLD FP 5 is for vaccination of healthy cows and heifers prior to breeding as an aid in preventing abortion caused by Infectious Bovine Rhinotracheitis (IBR), and by Bovine Virus Diarrhoea (BVD) virus Types 1 and 2 ; persistent calf infection caused by Bovine Virus Diarrhea (BVD) virus Types 1 and 2; respiratory disease caused by IBR, BVD Types 1 and 2, Parainfluenza3 (PI3) and Bovine Respiratory Syncytial Virus (BRSV); and BVD Types 1 and 2 testicular infection. A 12-month duration of immunity has been demonstrated against IBR-induced abortion and persistently infected calves caused by BVD Types 1 and 2. Bovi-Shield® GOLD FP 5 may be administered to pregnant cattle provided they were vaccinated according to label directions with any Bovi-Shield® FP vaccine within the past 12 months. Bovi-Shield® GOLD FP 5 may also be administered to calves nursing pregnant cows provided their dams were vaccinated within the past 12 months as described above. Warnings: Do not vaccinate within 21 days before slaughter. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions. Keep out of reach of children, uninformed persons and animals Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspect, seek veterinary advice and notify the registration holder. Storage: Store at 2 °C – 7 °C. Do not freeze.